Liver biopsy in liver transplantation: no additional risk of infections in patients with choledochojejunostomy

This study aimed to determine whether there is an increased infectious risk following liver biopsy in liver transplant patients with choledochojejunostomy. Methods: We evaluated the incidence of liver-biopsy-related sepsis in a consecutive series of 27 patients who underwent choledochojejunostomy, either during the transplant procedure (17 patients) or later following biliary complications (10 patients). We evaluated another 138 patients as a control group who had orthotopic liver transplantation during the same period and underwent duct-to-duct anastomosis. All liver biopsies had routine, prior ultrasound evaluation to detect dilated biliary ducts. Results: In the 27 patients who underwent choledochojejunostomy, 96 liver biopsies were performed: the sepsis rate was 3.12% per biopsy (n=96) or 7.4% per patient (n=27). However, despite a normal ultrasound, subsequent ERCP demonstrated biliary obstruction in one patient. Thus the rate of sepsis was 2.1% per biopsy or 3.7% per patient. In the control group 338 liver biopsies were performed: the sepsis rate was 1.5% per biopsy (n=338) or 2.9% per patient (n=138). The difference was not significant. All septic episodes had positive blood cultures for a single enteric microorganism, and all responded to antibodies. Conclusions: Our data do not suggest that liver-transplanted patients with choledochojejunostomy are more at risk of sepsis following liver biopsy, providing there is no “occult” biliary obstruction; therefore, they do not require prophylactic antibiotics as has been suggested by other authors